JHBR

Journal of Herbal and Biological Research

e ISSN:2394-1650:

Impact Factor:

editor@jhbrjournal.com

support@jhbrjournal.com

Molecular Docking Study of Novel Ligands Targeting EGFR Kinase Domain in Comparison with Erlotinib and Doxorubicin
Published: 2025-11-03

Omveer Kanojiya

neerajsharma236@gmail.com, Faculty of Pharmacy , Bhagwant University, Research Scholar , AjmerIndia

Keywords:Epidermal growth factor receptor (EGFR); AutoDock Vina; Erlotinib; Doxorubicin; Open Babel; Anticancer

ABSTRACT

ISSUE

Section

Articles

LICENSE

Copyright (c) 2022 Omveer Kanojiya,

Most read articles by the same author(s)

Molecular Docking Study of Novel Ligands Targeting EGFR Kinase Domain in Comparison with Erlotinib and Doxorubicin

Molecular Docking Study of Novel Ligands Targeting EGFR Kinase Domain in Comparison with Erlotinib and Doxorubicin

Anticancer Activity of Thiosemicarbazone Derivatives

Synthesis and Anticancer Activity of Thiosemicarbazone Derivatives